{"name":"CellinCells","slug":"cellincells","ticker":"","exchange":"","domain":"cellincells.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"TRTP-101","genericName":"TRTP-101","slug":"trtp-101","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"TRTP-101","genericName":"TRTP-101","slug":"trtp-101","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE53Vzd1MFhSb2xmMjBSNFNuaGxBTmtxdDBsMUQ1VWJqY29RcWVvT2JWWkktbEFqUTZCTTl6cXg5aDdUVjFDd3MydFhhRmNGeTBSM0JlV3JCdnFMdW1USW9hdUZ4T0NHdEZoNnRfVXEya0nSAXBBVV95cUxOd1c3dTBYUm9sZjIwUjRTbmhsQU5rcXQwbDFENVViamNvUXFlb09iVlpJLWxBalE2Qk05enF4OWg3VFYxQ3dzMnRYYUZjRnkwUjNCZVdyQnZxTHVtVElvYXVGeE9DR3RGaDZ0X1VxMmtJ?oc=5","date":"2026-04-08","type":"pipeline","source":"더바이오","summary":"﻿CELLinCELLS eyes year-end IPO… “Aiming to lead organoid innovation across skin, cartilage, and cancer” - 더바이오","headline":"﻿CELLinCELLS eyes year-end IPO… “Aiming to lead organoid innovation across skin, cartilage, and cancer” - 더바이오","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}